Bailard’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
AI
BI
PS
IFA
BC
HA
EC
Bailard's RCUS Position: Q4 2019 in Review
Bailard sold out of Arcus Biosciences (RCUS) in Q4 2019, closing a stake of 13,300 shares — an estimated $121K sold.
Bailard first reported a position in RCUS in Q4 2018 and held it in 4 quarters. The position peaked at $478K in Q1 2019. 75 funds tracked by Wall St. Rank hold RCUS as of Q4 2019.
- Bailard reported no remaining Arcus Biosciences position as of Q4 2019 after selling out during the quarter.
- Bailard sold 13,300 Arcus Biosciences shares in Q4 2019, an estimated $121K.
- Bailard first reported a position in Arcus Biosciences in Q4 2018 and held it in 4 quarters.
- Bailard's Arcus Biosciences position peaked at $478K in Q1 2019.
- 75 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2019.
Based on Bailard's 13F filing for Q4 2019, filed 31 Jan 2020.